|Articles|September 1, 2001

Examining the Issue of Nonsteroidal Anti-Inflammatory Drug-Associated Gastropathy
Volume 7
Issue 12 Suppl

Nonsteroidal Anti-Inflammatory Drugs, Cyclooxygenase Inhibitors, and the Risk of Gastrointestinal Complications

Download PDF: Nonsteroidal Anti-Inflammatory Drugs, Cyclooxygenase Inhibitors, and the Risk of Gastrointestinal Complications

Articles in this issue

almost 25 years ago

Article

The Importance of Addressing the Condition of Nonsteroidal Anti-Inflammatory Drug-Related Gastropathy

almost 25 years ago

Article

Participating Faculty

almost 25 years ago

Article

Upper Gastrointestinal Complications: The Causes, Consequences, and Clinical Outcomes

almost 25 years ago

Article

Helicobacter pylori and Nonsteroidal Anti-Inflammatory Drugs: Synergy or Null Effect?

almost 25 years ago

Article

Risk Stratification in Decisions about Nonsteroidal Anti-Inflammatory Drug-Related Gastropathy

almost 25 years ago

Article

CME/CPE Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Nonsteroidal Anti-Inflammatory Drugs, Cyclooxygenase Inhibitors, and the Risk of Gastrointestinal Complications

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

5 Ongoing Clinical Trials in Myeloproliferative Neoplasms

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Defunding Co-Payment Assistance Disrupted nAMD Care